| scholarly article | Q13442814 |
| P50 | author | Caitlin Hester | Q88959711 |
| P2093 | author name string | Amit G Singal | |
| Jorge A Marrero | |||
| Caitlin C Murphy | |||
| Neehar D Parikh | |||
| Adam C Yopp | |||
| Nicole E Rich | |||
| Mobolaji Odewole | |||
| P2860 | cites work | Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. | Q37338966 |
| Social networks, social support mechanisms, and quality of life after breast cancer diagnosis | Q37529326 | ||
| Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma | Q38812379 | ||
| Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US. | Q38954781 | ||
| Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. | Q39151731 | ||
| Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality. | Q39173460 | ||
| Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis | Q39483593 | ||
| Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. | Q39754109 | ||
| Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma | Q40136684 | ||
| Survival analysis of Hispanics in a cohort of patients with hepatocellular carcinoma | Q40211685 | ||
| Diagnostic delays are common among patients with hepatocellular carcinoma | Q40279432 | ||
| Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome | Q41690819 | ||
| Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma | Q43977142 | ||
| Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival | Q46493966 | ||
| Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. | Q46659877 | ||
| Epidemiology of hepatocellular carcinoma in Hispanics in the United States | Q46792059 | ||
| Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States | Q47620979 | ||
| Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma. | Q48124236 | ||
| Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry | Q48372554 | ||
| Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma | Q48744867 | ||
| Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review | Q26852154 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| Survival of blacks and whites after a cancer diagnosis | Q34124755 | ||
| Racial and ethnic disparities in the receipt of cancer treatment | Q34552950 | ||
| Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity | Q34667479 | ||
| Racial, social, and clinical determinants of hepatocellular carcinoma surveillance | Q34808945 | ||
| Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis | Q34902635 | ||
| Racial discrepancies in the outcome of patients with hepatocellular carcinoma | Q35894384 | ||
| Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort | Q36082793 | ||
| Failure rates in the hepatocellular carcinoma surveillance process. | Q36213610 | ||
| Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States | Q36540044 | ||
| Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States | Q37184472 | ||
| The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions | Q37234783 | ||
| P433 | issue | 3 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 551-559.e1 | |
| P577 | publication date | 2018-05-31 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma | |
| P478 | volume | 17 |
| Q92414362 | Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study |
| Q96231735 | Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma |
| Q99234116 | Cancer health disparities in racial/ethnic minorities in the United States |
| Q91829017 | Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma |
| Q64109847 | Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States |
| Q101461138 | Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort |
| Q90451979 | Hepatocellular Carcinoma: A Roadmap to Reduce Incidence and Future Burden |
| Q89524883 | Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis |
| Q90647244 | Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans |
| Q89623977 | Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity |
| Q60932796 | One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation |
| Q60920819 | Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma Are Not Explained by Differences in Comorbidities, Liver Disease Severity, or Tumor Burden |
| Q98163395 | Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis |
| Q91793155 | Socioeconomic And Survival Differences Among Minorities With Hepatocellular Carcinoma In Florida |
Search more.